相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Biochemical properties of human dehydrogenase/reductase (SDR family) member 7
Hana Stambergova et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Roles for the Backdoor Pathway of Androgen Metabolism in Prostate Cancer Response to Castration and Drug Treatment
Michael V. Fiandalo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer
Martina Kluth et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The Effects of Lycopene on the Methylation of the GSTP1 Promoter and Global Methylation in Prostatic Cancer Cell Lines PC3 and LNCaP
Li-Juan Fu et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Castration-resistant prostate cancer: latest evidence and therapeutic implications
Daniel L. Suzman et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2014)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development
Sandrine Marchais-Oberwinkler et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis
Emily A. Matuszak et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer
Tammy L. Romanuik et al.
BMC MEDICAL GENOMICS (2010)
Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
Matei Andreoiu et al.
HUMAN PATHOLOGY (2010)
The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative
Bengt Persson et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
Mohamed S. Arredouani et al.
CLINICAL CANCER RESEARCH (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9
Loredana Moro et al.
CANCER SCIENCE (2008)
Design and validation of specific inhibitors of 17β-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
Joanna M. Day et al.
ENDOCRINE-RELATED CANCER (2008)
Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: A study based on RTOG 9202
Mingxin Che et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Protein 4.1B suppresses prostate cancer progression and metastasis
Sunny Y. Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy
Ronney Abaza et al.
JOURNAL OF UROLOGY (2006)
Bioinformatic identification and characterization of new members of short-chain dehydrogenase/reductase superfamily
B Keller et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Cell lines used in prostate cancer research: A compendium of old and new lines - Part 1
RE Sobel et al.
JOURNAL OF UROLOGY (2005)
11β-hydroxysteroid dehydrogenases, cell proliferation and malignancy
EH Rabbitt et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in pro-state cancer
T Zellweger et al.
PROSTATE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)